GARADACIMAB

GARADACIMAB was reported 767 times

GARADACIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URETERONEOCYSTOSTOMY 1 0.1250
1 VASCULAR ACCESS SITE SCAR 1 0.1111
2 ULTRASOUND ABDOMEN 1 0.1000
3 LARYNGOSCOPY ABNORMAL 1 0.0833
4 HEREDITARY ANGIOEDEMA 498 0.0464
5 HEREDITARY ALPHA TRYPTASAEMIA 1 0.0455
6 VACCINATION SITE BRUISING 1 0.0417
7 COMPLEMENT DEFICIENCY DISEASE 1 0.0270
8 INDOLENT SYSTEMIC MASTOCYTOSIS 1 0.0238
9 LACK OF INFUSION SITE ROTATION 1 0.0208
10 IDIOPATHIC ENVIRONMENTAL INTOLERANCE 1 0.0204
11 TRACHEAL OPERATION 1 0.0192
12 COMPLEMENT FACTOR C4 INCREASED 1 0.0175
13 RADIATION ASSOCIATED HAEMORRHAGE 1 0.0169
14 CYCLOSPORIDIUM INFECTION 1 0.0169
15 PARATRACHEAL LYMPHADENOPATHY 2 0.0164
16 JUGULAR VEIN OCCLUSION 1 0.0154
17 JOINT INJECTION 2 0.0130
18 PHLEBOSCLEROSIS 1 0.0128
19 VASCULAR ACCESS SITE COMPLICATION 3 0.0119
20 INFUSION SITE ULCER 1 0.0109
21 PARAINFLUENZA VIRUS INFECTION 1 0.0097
22 REPETITIVE STRAIN INJURY 1 0.0088
23 VASCULAR ACCESS SITE PAIN 1 0.0083
24 RHINOPLASTY 1 0.0076
25 PULMONARY AIR LEAKAGE 1 0.0066
26 MALABSORPTION FROM INJECTION SITE 2 0.0065
27 DECREASED GAIT VELOCITY 1 0.0060
28 FACIAL DISCOMFORT 4 0.0056
29 LARYNGEAL DISORDER 4 0.0055
30 SPINAL CORD OPERATION 1 0.0052
31 TREATMENT DELAYED 9 0.0052
32 EXPOSURE TO EXTREME TEMPERATURE 1 0.0052
33 DEATH OF RELATIVE 2 0.0049
34 HEAVY EXPOSURE TO ULTRAVIOLET LIGHT 1 0.0047
35 SKIN PRESSURE MARK 1 0.0047
36 FEMALE REPRODUCTIVE TRACT DISORDER 1 0.0046
37 LARYNX IRRITATION 1 0.0043
38 MAST CELL ACTIVATION SYNDROME 6 0.0043
39 PILONIDAL DISEASE 1 0.0042
40 BREAST DISORDER FEMALE 1 0.0039
41 THUNDERCLAP HEADACHE 1 0.0038
42 VAGINAL CYST 1 0.0037
43 PERFUME SENSITIVITY 2 0.0035
44 ALLERGY TO METALS 2 0.0033
45 LARYNGEAL DISCOMFORT 2 0.0031
46 OESOPHAGEAL MOTILITY DISORDER 1 0.0028
47 INSURANCE ISSUE 42 0.0027
48 TRACHEOMALACIA 1 0.0025
49 MENINGEAL DISORDER 1 0.0025
50 REPRODUCTIVE TRACT DISORDER 1 0.0025
51 ALLERGY TO CHEMICALS 3 0.0024
52 VEIN RUPTURE 4 0.0024
53 CENTRAL VENOUS CATHETERISATION 7 0.0023
54 LACK OF SPONTANEOUS SPEECH 1 0.0023
55 PRODUCT DISTRIBUTION ISSUE 21 0.0023
56 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1 0.0022
57 ENLARGED UVULA 1 0.0022
58 PRODUCT RECONSTITUTION QUALITY ISSUE 2 0.0022
59 MINERAL SUPPLEMENTATION 1 0.0022
60 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
61 CRANIAL NERVE PARALYSIS 1 0.0021
62 HAEMANGIOMA CONGENITAL 1 0.0021
63 PLICATED TONGUE 1 0.0021
64 ANIMAL SCRATCH 2 0.0021
65 ROOT CANAL INFECTION 1 0.0020
66 SUSPECTED OFF LABEL USE 9 0.0020
67 BRAIN NEOPLASM BENIGN 1 0.0020
68 TRACHEAL DISORDER 1 0.0019
69 FAECAL VOLUME INCREASED 1 0.0019
70 INADEQUATE DIET 1 0.0019
71 POLYARTERITIS NODOSA 1 0.0017
72 BLOOD OESTROGEN INCREASED 1 0.0017
73 INFUSION SITE WARMTH 2 0.0016
74 INFUSION SITE PRURITUS 5 0.0016
75 INFUSION SITE IRRITATION 2 0.0016
76 MITE ALLERGY 1 0.0015
77 INFUSION SITE URTICARIA 1 0.0015
78 TRIPLE NEGATIVE BREAST CANCER 1 0.0015
79 PROCEDURAL ANXIETY 1 0.0015
80 GENITAL SWELLING 1 0.0014
81 CARDIAC SEPTAL DEFECT 1 0.0014
82 PHARYNGEAL DISORDER 4 0.0014
83 EMERGENCY CARE 4 0.0013
84 MYOPERICARDITIS 1 0.0013
85 POST-TRAUMATIC NECK SYNDROME 1 0.0012
86 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
87 DENTAL DISCOMFORT 1 0.0012
88 CRANIOFACIAL FRACTURE 1 0.0012
89 SPINAL CORD NEOPLASM 1 0.0011
90 THERAPY CHANGE 11 0.0011
91 MUSCLE SWELLING 1 0.0011
92 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
93 CATHETER SITE SWELLING 1 0.0011
94 BONE CYST 1 0.0011
95 LIP DISORDER 2 0.0011
96 INJECTION SITE SCAR 3 0.0011
97 PHARYNGEAL SWELLING 10 0.0010
98 DEVICE RELATED SEPSIS 2 0.0010
99 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
100 POOR VENOUS ACCESS 10 0.0010
101 INFUSION SITE SWELLING 6 0.0010
102 INFUSION SITE BRUISING 2 0.0009
103 INFUSION SITE MASS 1 0.0009
104 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
105 ORAL PRURITUS 2 0.0009
106 ADMINISTRATION SITE PAIN 1 0.0009
107 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
108 PAROTITIS 1 0.0009
109 MENOPAUSAL SYMPTOMS 2 0.0009
110 ALLODYNIA 1 0.0009
111 DISCOURAGEMENT 2 0.0009
112 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
113 WEIGHT ABNORMAL 2 0.0008
114 PAINFUL RESPIRATION 2 0.0008
115 DENTAL OPERATION 2 0.0008
116 VEIN DISORDER 4 0.0008
117 BRONCHIAL SECRETION RETENTION 1 0.0008
118 PHYSICAL DECONDITIONING 2 0.0008
119 RHONCHI 1 0.0007
120 SUDDEN ONSET OF SLEEP 1 0.0007
121 TRACHEOSTOMY 1 0.0007
122 POST HERPETIC NEURALGIA 1 0.0007
123 NOROVIRUS INFECTION 1 0.0007
124 ACUTE ABDOMEN 1 0.0007
125 ANKLE OPERATION 1 0.0007
126 SKIN STRIAE 1 0.0007
127 HEAT STROKE 1 0.0007
128 INJECTION SITE PARAESTHESIA 1 0.0007
129 LARYNGEAL OEDEMA 4 0.0006
130 BREAST CANCER RECURRENT 2 0.0006
131 PHARYNGEAL PARAESTHESIA 1 0.0006
132 PRODUCT PREPARATION ISSUE 4 0.0006
133 SYSTEMIC INFECTION 1 0.0006
134 THERAPY INTERRUPTED 43 0.0006
135 MEDICAL PROCEDURE 1 0.0006
136 LYME DISEASE 2 0.0006
137 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 2 0.0006
138 INFUSION SITE ERYTHEMA 5 0.0006
139 SPINAL CORD INJURY 1 0.0006
140 IMPRISONMENT 1 0.0006
141 GASTROINTESTINAL OEDEMA 1 0.0006
142 INTERCEPTED PRODUCT STORAGE ERROR 2 0.0006
143 PRODUCT SUPPLY ISSUE 4 0.0006
144 BODY TEMPERATURE ABNORMAL 1 0.0005
145 DENTAL CARE 1 0.0005
146 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
147 RHINOVIRUS INFECTION 2 0.0005
148 PURULENCE 1 0.0005
149 NASAL SEPTUM DEVIATION 1 0.0005
150 GENE MUTATION 1 0.0005
151 BLADDER DISORDER 5 0.0005
152 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
153 FRUSTRATION TOLERANCE DECREASED 4 0.0005
154 SUDDEN HEARING LOSS 1 0.0005
155 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
156 CHANGE OF BOWEL HABIT 1 0.0005
157 DEVICE CONNECTION ISSUE 1 0.0005
158 INJECTION SITE IRRITATION 6 0.0005
159 JAW FRACTURE 1 0.0005
160 HORDEOLUM 2 0.0005
161 MIDDLE EAR EFFUSION 1 0.0005
162 FEAR OF DEATH 1 0.0004
163 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
164 HAEMANGIOMA 1 0.0004
165 INGROWING NAIL 1 0.0004
166 ENDOMETRIOSIS 2 0.0004
167 BRONCHITIS CHRONIC 1 0.0004
168 ORAL DISORDER 3 0.0004
169 HAEMATOLOGICAL INFECTION 1 0.0004
170 DERMAL CYST 1 0.0004
171 PRODUCT AVAILABILITY ISSUE 9 0.0004
172 FOOD ALLERGY 3 0.0004
173 MENOPAUSE 1 0.0004
174 DRUG TITRATION ERROR 1 0.0004
175 LIPOMA 1 0.0004
176 CATHETER SITE PAIN 1 0.0004
177 HERNIA REPAIR 1 0.0004
178 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
179 BRAIN FOG 6 0.0004
180 INJECTION SITE DISCHARGE 2 0.0004
181 LARYNGOSPASM 1 0.0004
182 ABDOMINAL RIGIDITY 1 0.0004
183 MIGRAINE WITH AURA 1 0.0004
184 ORAL FUNGAL INFECTION 1 0.0004
185 ENDOTRACHEAL INTUBATION 1 0.0004
186 PERIORBITAL SWELLING 2 0.0004
187 BREAST CANCER STAGE IV 1 0.0004
188 NEUROLOGICAL SYMPTOM 2 0.0003
189 ADENOVIRUS INFECTION 1 0.0003
190 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
191 STRIDOR 1 0.0003
192 ENERGY INCREASED 2 0.0003
193 INFUSION SITE REACTION 1 0.0003
194 URINE ANALYSIS ABNORMAL 1 0.0003
195 ATYPICAL PNEUMONIA 1 0.0003
196 HEAVY MENSTRUAL BLEEDING 3 0.0003
197 THERAPY CESSATION 17 0.0003
198 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
199 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
200 PRODUCT USE ISSUE 60 0.0003
201 PNEUMOTHORAX 5 0.0003
202 ILLNESS 32 0.0003
203 LIGAMENT SPRAIN 3 0.0003
204 NEAR DEATH EXPERIENCE 1 0.0003
205 APPETITE DISORDER 2 0.0003
206 SWELLING 28 0.0003
207 POSTOPERATIVE WOUND INFECTION 2 0.0003
208 NEOPLASM RECURRENCE 1 0.0003
209 PRODUCT DOSE OMISSION ISSUE 83 0.0003
210 TONGUE DISORDER 2 0.0003
211 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
212 HOSPITALISATION 42 0.0003
213 SENSITIVE SKIN 2 0.0003
214 GASTRIC INFECTION 1 0.0003
215 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
216 OESOPHAGEAL DISORDER 1 0.0003
217 CONCUSSION 2 0.0003
218 ABNORMAL FAECES 2 0.0002
219 SOCIAL PROBLEM 1 0.0002
220 ANAPHYLACTIC REACTION 13 0.0002
221 INJECTION SITE SWELLING 18 0.0002
222 PURULENT DISCHARGE 1 0.0002
223 PRODUCT DISPENSING ISSUE 1 0.0002
224 PRODUCT CONTAINER ISSUE 2 0.0002
225 ANURIA 2 0.0002
226 URINE OUTPUT DECREASED 2 0.0002
227 RHINITIS ALLERGIC 1 0.0002
228 OROPHARYNGEAL DISCOMFORT 2 0.0002
229 CYSTITIS 7 0.0002
230 IMMUNE THROMBOCYTOPENIA 1 0.0002
231 ILL-DEFINED DISORDER 13 0.0002
232 FLANK PAIN 2 0.0002
233 SEASONAL ALLERGY 3 0.0002
234 SKIN ABRASION 1 0.0002
235 INTENTIONAL DOSE OMISSION 6 0.0002
236 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
237 LIMB OPERATION 1 0.0002
238 RASH VESICULAR 1 0.0002
239 HORMONE LEVEL ABNORMAL 1 0.0002
240 ANEURYSM 1 0.0002
241 RESPIRATORY DISORDER 6 0.0002
242 SALIVARY HYPERSECRETION 2 0.0002
243 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
244 SLUGGISHNESS 2 0.0002
245 MUSCULOSKELETAL CHEST PAIN 3 0.0002
246 TEMPERATURE INTOLERANCE 2 0.0002
247 ANKLE FRACTURE 3 0.0002
248 VARICOSE VEIN 1 0.0002
249 WEIGHT FLUCTUATION 2 0.0002
250 PARTIAL SEIZURES 1 0.0002
251 PRODUCT USE COMPLAINT 3 0.0002
252 GASTROINTESTINAL DISORDER 17 0.0002
253 JOINT DISLOCATION 2 0.0002
254 WEIGHT INCREASED 42 0.0002
255 GINGIVITIS 1 0.0002
256 CHEILITIS 1 0.0002
257 TIC 1 0.0002
258 JAW DISORDER 1 0.0002
259 NONSPECIFIC REACTION 1 0.0002
260 CHOKING SENSATION 1 0.0002
261 DENTAL CARIES 2 0.0002
262 VIRAL INFECTION 6 0.0002
263 INJECTION SITE PRURITUS 12 0.0002
264 INTERMENSTRUAL BLEEDING 1 0.0002
265 PRODUCT LEAKAGE 1 0.0002
266 DERMATITIS CONTACT 2 0.0002
267 MOUTH SWELLING 1 0.0002
268 ENTEROCOLITIS 1 0.0002
269 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
270 METASTASES TO LUNG 2 0.0002
271 DEVICE DEFECTIVE 3 0.0002
272 WEIGHT DECREASED 48 0.0002
273 SYRINGE ISSUE 3 0.0002
274 SURGERY 10 0.0002
275 URINE ODOUR ABNORMAL 1 0.0002
276 NEURALGIA 4 0.0002
277 GENERALISED OEDEMA 2 0.0002
278 OLIGURIA 1 0.0002
279 INFUSION SITE EXTRAVASATION 1 0.0002
280 PRE-EXISTING CONDITION IMPROVED 1 0.0002
281 BLEPHAROSPASM 1 0.0002
282 FOOT FRACTURE 3 0.0002
283 PHOTOPSIA 1 0.0002
284 ENTERITIS 1 0.0002
285 ROTATOR CUFF SYNDROME 2 0.0002
286 INJECTION SITE INDURATION 2 0.0002
287 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
288 INJECTION SITE ERYTHEMA 19 0.0002
289 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
290 KIDNEY INFECTION 3 0.0002
291 BEDRIDDEN 2 0.0002
292 ORAL CANDIDIASIS 2 0.0002
293 DYSGRAPHIA 1 0.0002
294 CORONAVIRUS INFECTION 1 0.0002
295 ADVERSE REACTION 2 0.0002
296 PRODUCT ADMINISTRATION ERROR 3 0.0001
297 SINUS CONGESTION 2 0.0001
298 ECCHYMOSIS 1 0.0001
299 DROOLING 1 0.0001
300 LYMPHOEDEMA 1 0.0001
301 APHONIA 2 0.0001
302 MASS 2 0.0001
303 SKIN REACTION 2 0.0001
304 HAND FRACTURE 1 0.0001
305 JOINT INJURY 3 0.0001
306 PARALYSIS 2 0.0001
307 RHINORRHOEA 9 0.0001
308 PARAESTHESIA ORAL 2 0.0001
309 PANIC REACTION 1 0.0001
310 VISUAL FIELD DEFECT 1 0.0001
311 URTICARIA 23 0.0001
312 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
313 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
314 INTENTIONAL UNDERDOSE 1 0.0001
315 MIGRAINE 13 0.0001
316 ANGIOEDEMA 6 0.0001
317 BLINDNESS TRANSIENT 1 0.0001
318 PSYCHIATRIC SYMPTOM 1 0.0001
319 CEREBRAL DISORDER 1 0.0001
320 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
321 PULMONARY MASS 2 0.0001
322 UNEVALUABLE EVENT 10 0.0001
323 HIP ARTHROPLASTY 2 0.0001
324 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
325 INJECTION SITE RASH 4 0.0001
326 ABDOMINAL PAIN 30 0.0001
327 APHTHOUS ULCER 1 0.0001
328 THERAPY PARTIAL RESPONDER 2 0.0001
329 NERVOUS SYSTEM DISORDER 4 0.0001
330 TREATMENT NONCOMPLIANCE 7 0.0001
331 MULTIPLE ALLERGIES 1 0.0001
332 AFFECTIVE DISORDER 1 0.0001
333 RESPIRATORY TRACT CONGESTION 2 0.0001
334 RHINITIS 1 0.0001
335 STENT PLACEMENT 1 0.0001
336 ADVERSE DRUG REACTION 11 0.0001
337 INJECTION SITE URTICARIA 3 0.0001
338 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
339 EMBOLISM 1 0.0001
340 LIP SWELLING 4 0.0001
341 URINARY RETENTION 4 0.0001
342 ROAD TRAFFIC ACCIDENT 5 0.0001
343 SENSATION OF FOREIGN BODY 1 0.0001
344 HYPOPHAGIA 3 0.0001
345 ANAPHYLACTIC SHOCK 3 0.0001
346 INJECTION SITE REACTION 8 0.0001
347 MUSCULOSKELETAL DISCOMFORT 2 0.0001
348 DYSPHAGIA 11 0.0001
349 BLOOD MAGNESIUM DECREASED 1 0.0001
350 CARDIAC MURMUR 1 0.0001
351 HYSTERECTOMY 1 0.0001
352 MENTAL DISORDER 5 0.0001
353 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
354 SPEECH DISORDER 6 0.0001
355 GROIN PAIN 1 0.0001
356 SPINAL OSTEOARTHRITIS 1 0.0001
357 EAR INFECTION 3 0.0001
358 FACIAL PAIN 1 0.0001
359 THIRST 2 0.0001
360 HAEMARTHROSIS 1 0.0001
361 THROAT TIGHTNESS 3 0.0001
362 LIMB INJURY 3 0.0001
363 LIP DRY 1 0.0001
364 PNEUMONIA BACTERIAL 1 0.0001
365 INCREASED TENDENCY TO BRUISE 1 0.0001
366 PERSONALITY CHANGE 1 0.0001
367 DIARRHOEA HAEMORRHAGIC 1 0.0001
368 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
369 ABDOMINAL DISTENSION 11 0.0001
370 FEELING JITTERY 2 0.0001
371 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
372 POST PROCEDURAL COMPLICATION 2 0.0001
373 HERNIA 2 0.0001
374 EAR PAIN 2 0.0001
375 AUTOIMMUNE DISORDER 1 0.0001
376 KNEE OPERATION 1 0.0001
377 INABILITY TO AFFORD MEDICATION 1 0.0001
378 INJECTION SITE BRUISING 8 0.0001
379 POOR QUALITY DEVICE USED 1 0.0001
380 LACRIMATION INCREASED 3 0.0001
381 TOOTH ABSCESS 1 0.0001
382 SUBARACHNOID HAEMORRHAGE 1 0.0001
383 EUPHORIC MOOD 1 0.0001
384 SINUSITIS 10 0.0001
385 INITIAL INSOMNIA 1 0.0001
386 INJECTION SITE WARMTH 2 0.0001
387 HYPERSENSITIVITY 18 0.0001
388 LIMB DISCOMFORT 3 0.0001
389 INJECTION SITE DISCOMFORT 1 0.0001
390 KNEE ARTHROPLASTY 2 0.0001
391 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
392 IMPAIRED WORK ABILITY 2 0.0001
393 NASOPHARYNGITIS 17 0.0001
394 OEDEMA 5 0.0001
395 SWELLING FACE 6 0.0001
396 BACK INJURY 1 0.0001
397 PRODUCT PRESCRIBING ISSUE 2 0.0001
398 PULMONARY THROMBOSIS 1 0.0001
399 OESOPHAGITIS 1 0.0001
400 WOUND INFECTION 1 0.0001
401 GASTROINTESTINAL PAIN 1 0.0001
402 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
403 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
404 EYE PRURITUS 3 0.0001
405 RASH PAPULAR 2 0.0001
406 DEVICE ISSUE 8 0.0001
407 EYE INFECTION 1 0.0001
408 INJECTION SITE PAIN 27 0.0001
409 IMPAIRED DRIVING ABILITY 1 0.0001
410 INTERNAL HAEMORRHAGE 1 0.0001
411 EYELID OEDEMA 1 0.0001
412 CARDIAC DISORDER 8 0.0001
413 DYSPHONIA 5 0.0001
414 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
415 WRIST FRACTURE 1 0.0001
416 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
417 THERAPEUTIC RESPONSE DECREASED 5 0.0001
418 PRESYNCOPE 2 0.0001
419 CARDIOMEGALY 1 0.0001
420 SPINAL OPERATION 1 0.0001
421 ABNORMAL WEIGHT GAIN 1 0.0001
422 INFLUENZA 9 0.0001
423 PHARYNGITIS 1 0.0001
424 TOOTH EXTRACTION 1 0.0001
425 PNEUMONIA ASPIRATION 2 0.0001
426 INJECTION SITE DISCOLOURATION 1 0.0001
427 SECRETION DISCHARGE 1 0.0001
428 BRAIN OEDEMA 1 0.0001
429 CHEST DISCOMFORT 8 0.0001
430 INFUSION SITE PAIN 1 0.0001
431 EXPOSURE VIA SKIN CONTACT 2 0.0001
432 RESPIRATORY TRACT INFECTION 2 0.0001
433 NODULE 1 0.0001
434 DEAFNESS 2 0.0001
435 INFECTION 11 0.0001
436 TOOTH INFECTION 1 0.0001
437 OROPHARYNGEAL PAIN 7 0.0001
438 MALIGNANT MELANOMA 1 0.0001
439 QUALITY OF LIFE DECREASED 1 0.0001
440 IMPAIRED GASTRIC EMPTYING 1 0.0001
441 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
442 CONTUSION 7 0.0001
443 PROCEDURAL PAIN 2 0.0001
444 HUNGER 1 0.0001
445 DEMENTIA 2 0.0001
446 ABDOMINAL DISCOMFORT 12 0.0001
447 CARPAL TUNNEL SYNDROME 1 0.0001
448 DEVICE MALFUNCTION 5 0.0001
449 DEVICE OCCLUSION 1 0.0001
450 DRUG INEFFECTIVE 93 0.0001
451 BRONCHOSPASM 1 0.0001
452 HYPERSOMNIA 2 0.0001
453 ACCIDENTAL UNDERDOSE 1 0.0001
454 DEVICE LEAKAGE 3 0.0001
455 GASTROENTERITIS 1 0.0001
456 MALAISE 30 0.0001
457 THROAT IRRITATION 3 0.0001
458 NEPHROLITHIASIS 3 0.0001
459 TINNITUS 3 0.0001
460 FEELING HOT 4 0.0001
461 HYPOKALAEMIA 3 0.0001
462 DEVICE RELATED INFECTION 1 0.0001
463 LYMPHOMA 1 0.0001
464 RENAL DISORDER 3 0.0001
465 BASAL CELL CARCINOMA 1 0.0001
466 SWOLLEN TONGUE 2 0.0001
467 HEAD INJURY 2 0.0001
468 PAIN 38 0.0001
469 MUSCLE TIGHTNESS 1 0.0001
470 BACK DISORDER 1 0.0001
471 INCORRECT DOSE ADMINISTERED 14 0.0001
472 COAGULOPATHY 1 0.0001
473 GAIT INABILITY 2 0.0001
474 PNEUMONIA 19 0.0001
475 SCAR 1 0.0001
476 PARANOIA 1 0.0001
477 RASH MACULAR 2 0.0001
478 MUSCULOSKELETAL STIFFNESS 5 0.0001
479 PANCREATITIS 3 0.0001
480 DEPRESSED MOOD 3 0.0001
481 HEAD DISCOMFORT 1 0.0001
482 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
483 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
484 GALLBLADDER DISORDER 1 0.0001
485 CONDITION AGGRAVATED 17 0.0001
486 GASTROENTERITIS VIRAL 1 0.0001
487 FATIGUE 43 0.0001
488 PANIC ATTACK 2 0.0001
489 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
490 CONJUNCTIVITIS 1 0.0001
491 EYE SWELLING 2 0.0001
492 HEPATIC STEATOSIS 1 0.0001
493 MIDDLE INSOMNIA 1 0.0001
494 PHOTOPHOBIA 1 0.0001
495 ASTHMA 6 0.0001
496 MUSCULAR WEAKNESS 6 0.0001
497 URINARY TRACT INFECTION 9 0.0001
498 SLEEP APNOEA SYNDROME 1 0.0001
499 INCREASED APPETITE 1 0.0001
500 LETHARGY 3 0.0001
501 ACUTE RESPIRATORY FAILURE 1 0.0001
502 GLAUCOMA 1 0.0001
503 CHOKING 1 0.0001
504 HEADACHE 32 0.0001
505 DISABILITY 1 0.0001
506 SINUS DISORDER 1 0.0001
507 HEART RATE INCREASED 5 0.0001
508 BLOOD PRESSURE ABNORMAL 1 0.0001
509 PRESCRIBED UNDERDOSE 1 0.0001
510 PREGNANCY 1 0.0000
511 PRODUCT PHYSICAL ISSUE 1 0.0000
512 STOMATITIS 3 0.0000
513 FEEDING DISORDER 1 0.0000
514 DYSKINESIA 2 0.0000
515 ANXIETY 14 0.0000
516 DISCOMFORT 3 0.0000
517 RIB FRACTURE 1 0.0000
518 INFLUENZA LIKE ILLNESS 4 0.0000
519 CHEST PAIN 9 0.0000
520 POLLAKIURIA 2 0.0000
521 HAEMORRHAGE 5 0.0000
522 DERMATITIS 1 0.0000
523 MOUTH ULCERATION 1 0.0000
524 PYREXIA 16 0.0000
525 FAECES DISCOLOURED 1 0.0000
526 SEPTIC SHOCK 2 0.0000
527 FEELING ABNORMAL 11 0.0000
528 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
529 PRODUCT STORAGE ERROR 4 0.0000
530 PERIPHERAL SWELLING 7 0.0000
531 BLOOD PRESSURE DECREASED 3 0.0000
532 FALL 15 0.0000
533 TOOTH DISORDER 1 0.0000
534 NEOPLASM MALIGNANT 3 0.0000
535 GLOSSODYNIA 1 0.0000
536 PULMONARY OEDEMA 2 0.0000
537 SNEEZING 1 0.0000
538 THERAPY NON-RESPONDER 2 0.0000
539 PANCREATITIS ACUTE 1 0.0000
540 CHROMATURIA 1 0.0000
541 HEPATIC ENZYME INCREASED 3 0.0000
542 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
543 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
544 COUGH 12 0.0000
545 PALPITATIONS 5 0.0000
546 INJURY 3 0.0000
547 TREMOR 7 0.0000
548 NEUROPATHY PERIPHERAL 4 0.0000
549 RASH ERYTHEMATOUS 2 0.0000
550 MENTAL IMPAIRMENT 1 0.0000
551 UNDERDOSE 3 0.0000
552 AGITATION 3 0.0000
553 AGEUSIA 1 0.0000
554 DRY EYE 2 0.0000
555 ABDOMINAL PAIN LOWER 1 0.0000
556 NAUSEA 31 0.0000
557 HEPATITIS 1 0.0000
558 LOSS OF CONSCIOUSNESS 5 0.0000
559 ABDOMINAL PAIN UPPER 8 0.0000
560 OFF LABEL USE 34 0.0000
561 HYPERHIDROSIS 5 0.0000
562 INFLAMMATION 2 0.0000
563 UNRESPONSIVE TO STIMULI 1 0.0000
564 NERVOUSNESS 2 0.0000
565 ECZEMA 2 0.0000
566 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
567 MUSCLE SPASMS 7 0.0000
568 GASTRITIS 1 0.0000
569 INJECTION SITE HAEMORRHAGE 3 0.0000
570 DEHYDRATION 5 0.0000
571 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
572 FEAR 1 0.0000
573 FREQUENT BOWEL MOVEMENTS 1 0.0000
574 DRY MOUTH 3 0.0000
575 MOOD ALTERED 1 0.0000
576 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
577 RESPIRATORY ARREST 1 0.0000
578 RESPIRATORY DISTRESS 1 0.0000
579 SEPSIS 4 0.0000
580 HAEMOPTYSIS 1 0.0000
581 NECK PAIN 2 0.0000
582 DIARRHOEA 23 0.0000
583 FLATULENCE 2 0.0000
584 SEIZURE 4 0.0000
585 NEEDLE ISSUE 1 0.0000
586 DYSSTASIA 1 0.0000
587 COVID-19 6 0.0000
588 CHILLS 4 0.0000
589 NASAL CONGESTION 2 0.0000
590 LABORATORY TEST ABNORMAL 1 0.0000
591 PSYCHOTIC DISORDER 1 0.0000
592 INSOMNIA 9 0.0000
593 WHEEZING 2 0.0000
594 CATARACT 2 0.0000
595 DYSPNOEA 19 0.0000
596 IRRITABILITY 2 0.0000
597 BLOOD POTASSIUM DECREASED 1 0.0000
598 ADVERSE EVENT 3 0.0000
599 EXPOSURE DURING PREGNANCY 2 0.0000
600 DIZZINESS 16 0.0000
601 PULMONARY EMBOLISM 3 0.0000
602 GAIT DISTURBANCE 6 0.0000
603 HYPOTHYROIDISM 1 0.0000
604 MOVEMENT DISORDER 1 0.0000
605 HIP FRACTURE 1 0.0000
606 DEPRESSION 7 0.0000
607 DYSPEPSIA 3 0.0000
608 IMPAIRED HEALING 1 0.0000
609 STAPHYLOCOCCAL INFECTION 1 0.0000
610 EXPIRED PRODUCT ADMINISTERED 1 0.0000
611 FUNGAL INFECTION 1 0.0000
612 SKIN DISORDER 1 0.0000
613 VOMITING 14 0.0000
614 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
615 ASTHENIA 11 0.0000
616 HAEMATURIA 1 0.0000
617 MEMORY IMPAIRMENT 4 0.0000
618 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
619 PRURITUS 11 0.0000
620 HEART RATE DECREASED 1 0.0000
621 SLEEP DISORDER 2 0.0000
622 CRYING 1 0.0000
623 DYSURIA 1 0.0000
624 BRONCHITIS 2 0.0000
625 HYPOAESTHESIA 4 0.0000
626 DYSARTHRIA 1 0.0000
627 HOT FLUSH 2 0.0000
628 INTESTINAL OBSTRUCTION 1 0.0000
629 COLITIS 1 0.0000
630 BACK PAIN 6 0.0000
631 ARTHRITIS 2 0.0000
632 DISORIENTATION 1 0.0000
633 DRUG INTERACTION 4 0.0000
634 THROMBOSIS 2 0.0000
635 JOINT SWELLING 3 0.0000
636 SOMNOLENCE 5 0.0000
637 EMOTIONAL DISTRESS 3 0.0000
638 EXTRA DOSE ADMINISTERED 1 0.0000
639 VISUAL IMPAIRMENT 3 0.0000
640 ARTHRALGIA 10 0.0000
641 RENAL IMPAIRMENT 2 0.0000
642 PAIN IN EXTREMITY 7 0.0000
643 MYALGIA 4 0.0000
644 HYPOACUSIS 1 0.0000
645 DEVICE DISLOCATION 1 0.0000
646 CONSTIPATION 5 0.0000
647 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
648 SKIN DISCOLOURATION 1 0.0000
649 DECREASED APPETITE 5 0.0000
650 COGNITIVE DISORDER 1 0.0000
651 DRUG INTOLERANCE 2 0.0000
652 INTERSTITIAL LUNG DISEASE 1 0.0000
653 RASH 9 0.0000
654 LUNG DISORDER 1 0.0000
655 AGGRESSION 1 0.0000
656 CELLULITIS 1 0.0000
657 BLOOD PRESSURE INCREASED 3 0.0000
658 ERYTHEMA 4 0.0000
659 MUSCULOSKELETAL PAIN 1 0.0000
660 DERMATITIS ATOPIC 1 0.0000
661 BRADYCARDIA 1 0.0000
662 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
663 CONFUSIONAL STATE 3 0.0000
664 DISTURBANCE IN ATTENTION 1 0.0000
665 RASH PRURITIC 1 0.0000
666 HAEMATOCHEZIA 1 0.0000
667 BLISTER 1 0.0000
668 OXYGEN SATURATION DECREASED 1 0.0000
669 EYE PAIN 1 0.0000
670 RHEUMATOID ARTHRITIS 2 0.0000
671 HERPES ZOSTER 1 0.0000
672 MYOCARDIAL INFARCTION 3 0.0000
673 BONE PAIN 1 0.0000
674 PLEURAL EFFUSION 1 0.0000
675 VERTIGO 1 0.0000
676 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
677 INTENTIONAL OVERDOSE 1 0.0000
678 INFUSION RELATED REACTION 1 0.0000
679 DRY SKIN 2 0.0000
680 BURNING SENSATION 1 0.0000
681 SKIN BURNING SENSATION 1 0.0000
682 MOBILITY DECREASED 1 0.0000
683 RESPIRATORY FAILURE 1 0.0000
684 DYSGEUSIA 1 0.0000
685 EPISTAXIS 1 0.0000
686 CHRONIC KIDNEY DISEASE 1 0.0000
687 CARDIAC FAILURE 1 0.0000
688 CARDIAC ARREST 1 0.0000
689 SKIN EXFOLIATION 1 0.0000
690 CEREBROVASCULAR ACCIDENT 2 0.0000
691 BALANCE DISORDER 1 0.0000
692 INTENTIONAL PRODUCT MISUSE 1 0.0000
693 TACHYCARDIA 1 0.0000
694 BREAST CANCER 1 0.0000
695 ANAEMIA 2 0.0000
696 ALOPECIA 2 0.0000
697 SYNCOPE 1 0.0000
698 HYPOTENSION 2 0.0000
699 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
700 FLUSHING 1 0.0000
701 HYPERTENSION 2 0.0000
702 PSORIASIS 1 0.0000
703 VISION BLURRED 1 0.0000
704 PARAESTHESIA 1 0.0000
705 DEATH 3 0.0000